In Brief This Week: Abbott; Waters; Affymetrix; Cleveland Diagnostics; Cepheid; Evotec, J&J; Sigma-Aldrich; Thermo Fisher; More | GenomeWeb

NEW YORK (GenomeWeb News) – Abbott this week said that the US Food and Drug Administration recently approved the expanded use of the firm's RealTime HCV and RealTime HBV assay to run on the m2000 RealTime system.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

This Week in Science: New research into the emergence of infectious diseases, and scientists report on proteins involved in melanoma.

The hashtag #stupidcommonnames is gaining fans among scientists who find the common names of some animals and plants dumb.

Fed up with budget slashes, job cuts, and muzzling mandates, researchers in Canada are making science a campaign issue in the upcoming elections.

A former NIH program officer says the Internet has blasted open the door for scientific publications more interested in dollars than quality research.